Home/ Stocks/ PLSE

Pulse Biosciences, Inc Common Stock (DE)

PLSE XNAS

$42.41 +4.03 (+10.53%) ▲ 15-min delayed

Open

$37.84

High

$45.90

Low

$37.40

Volume

734.6K

Market Cap

$2.65B

About Pulse Biosciences, Inc Common Stock (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.

Sector: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS Employees: 116 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$401.0K	$-18,581,000	$-0.27
FY 2025	$350.0K	$-72,781,000	$-1.08
Q3 2025	$86.0K	$-19,385,000	$-0.29
Q2 2025	$0	$-19,168,000	$-0.28

Earnings & Analyst Ratings

Next Earnings: Tue, Nov 3, 2026

Calendar →

Related Market News

No specific coverage for PLSE yet. Check out our latest market news or earnings calendar.

Get PLSE Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Pulse Biosciences, Inc Common Stock (DE).

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.